Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease

Journal of Rheumatology

Volumn 20, Issue 5, 1993, Pages 838-844

  Silver, R M ^a   Warrick, J H ^a   Kinsella, M B ^a   Staudt, L S ^a   Baumann, M H ^a   Strange, C ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

alveolitis; cyclophosphamide; pulmonary function; scleroderma; systemic sclerosis; treatment

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CYSTITIS; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LEUKOPENIA; MALE; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; THROMBOCYTOPENIA;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CYCLOPHOSPHAMIDE; FEMALE; HUMAN; MALE; MIDDLE AGE; PREDNISONE; PROSPECTIVE STUDIES; PULMONARY DIFFUSING CAPACITY; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VITAL CAPACITY;

EID: 0027314630     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)